Main pipeline
2025 | 2027 | 2029 | 2031 | ||
 |  |  | |||
Indication | Discovery | Preclinical | Phase1 | Phase2 | Phase3 |
| Pancreatic cancer inhibitor 1 (CY101) |  | ||||
| Pancreatic cancer inhibitor 2 (GJ101) |  | ||||
| Lung cancer inhibitor (GJ501) |  | ||||
| Colorectal cancer inhibitor (GJ105) |  | ||||
| Cancer of the liver inhibitor (GJ108) |  | ||||
| A cure for dementia (GJ106) |  | ||||
| Anti-inflammatory drugs (GJ107) |  | ||||
| Virus inhibitors |  | ||||
| Diagnosis kits |  | ||||
